Quantcast

Latest Nephrotic syndrome Stories

2011-03-01 15:05:00

ROSLYN, N.Y., March 1, 2011 /PRNewswire/ -- Gotham Government Relations and Communications today announced a new pro-bono client: The NephCure Foundation. The NephCure Foundation is the only organization committed exclusively to support education and research seeking the cause of the potentially debilitating kidney diseases, Nephrotic Syndrome and Focal Segmental Glomerulosclerosis (FSGS), improve treatment and find a cure. "Unfortunately, these two diseases are extremely debilitating...

2011-02-24 05:30:00

ANAHEIM, Calif., Feb. 24, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) announced today that executive management will present at the following investor conferences during the first week of March 2011: The Citi Global Healthcare Conference in New York City. Don M. Bailey, President and Chief Executive Officer, is scheduled to present an overview of the Company on Tuesday, March 1, 2011 at 9:00 a.m. ET. The RBC Capital Markets Healthcare Conference in New York...

2011-02-23 15:05:00

ANAHEIM, Calif., Feb. 23, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today reported financial results for the full year and fourth quarter ended December 31, 2010. For the year ended December 31, 2010, net sales increased 30.4 percent to a record $115.1 million from $88.3 million in the prior year. The Company's financial performance was driven by an increase in net sales for H.P. Acthar® Gel (Acthar), for the treatment of acute...

2011-02-16 05:30:00

ANAHEIM, Calif., Feb. 16, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced that Standard & Poor's (S&P) will add the Company to the S&P SmallCap 600 Index effective after the close of the U.S. financial markets on February 17, 2011. "Our inclusion in the S&P SmallCap 600 Index reflects our consistent financial performance, and will serve to increase our visibility within the investment community as we continue our efforts to grow sales...

2011-02-07 05:30:00

ANAHEIM, Calif., Feb. 7, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced that it will release financial results for the fourth quarter and full year ended December 31, 2010 on Wednesday, February 23, 2011 after the close of the U.S. financial markets. The Company will host a conference call and webcast on Wednesday, February 23, 2011 at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss results and highlights of the fourth quarter and full year 2010, as...

2011-01-10 06:15:00

ANAHEIM, Calif., Jan. 10, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today reported a strong finish to 2010. The Company estimates that 353 new, paid Acthar prescriptions for the treatment of multiple sclerosis (MS) were filled and shipped during the quarter, up 66% from the year ago period and up 9% from the third quarter of 2010. 1,680 vials and 6,666 vials of the company's principal drug, H.P. Acthar® Gel, were shipped during the quarter and...

2011-01-07 17:20:00

ANAHEIM, Calif., Jan. 7, 2011 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) announced today that its presentation at the 29th Annual J.P. Morgan Healthcare Conference has been rescheduled for 9:00 a.m. PT on Monday, January 10, 2011 at the Westin St. Francis Hotel in San Francisco. Questcor was originally scheduled to present at 2:00 p.m. PT on Thursday, January 13, 2011. Don M. Bailey, President and Chief Executive Officer, will review the Company's business strategy and...

2010-12-20 05:30:00

ANAHEIM, Calif., Dec. 20, 2010 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) announced today that it will present at the 29th Annual J.P. Morgan Healthcare Conference at 12:00 p.m. PT on Thursday, January 13, 2011 at the Westin St. Francis Hotel in San Francisco, California. Don M. Bailey, President and Chief Executive Officer, will review the Company's business strategy and recent corporate developments. A live audio and slides webcast of Questcor's presentation may be...

2010-12-13 13:08:56

University of Alabama at Birmingham researchers have pinpointed a protein that compromises the kidney's filtering ability, causing nephrotic syndrome, and demonstrated that a naturally occurring precursor of an acid in the body offers potential for treating some forms of the condition. The research was published online Dec. 12 in Nature Medicine. "This is a major breakthrough in understanding the development and treatment of kidney disease associated with proteinuria, the leakage of protein...

2010-11-22 05:30:00

DENVER, Nov. 22, 2010 /PRNewswire/ -- On November 20 at the American Society of Nephrology (ASN) 43rd Annual Meeting, interim results presented from an ongoing, randomized prospective study conducted independently by James A. Tumlin, MD, at the University of Tennessee College of Medicine Chattanooga indicated that 9 of 15 patients (60%) with advanced diabetic nephropathy who are currently enrolled in the study and have completed or are still undergoing a six month course of treatment...


Word of the Day
cock-a-hoop
  • Exultant; jubilant; triumphant; on the high horse.
  • Tipsy; slightly intoxicated.
This word may come from the phrase 'to set cock on hoop,' or 'to drink festively.' Its origin otherwise is unclear. A theory, according to the Word Detective, is that it's a 'transliteration of the French phrase 'coq a huppe,' meaning a rooster displaying its crest ('huppe') in a pose of proud defiance.' Therefore, 'cock-a-hoop' would 'liken a drunken man to a boastful and aggressive rooster.'
Related